News
= LISA News
24.11.2020
Wissenschaftler der Privatuniversität UMIT TIROL präsentieren Entscheidungsgrundlage für gezielte COVID-19 Impfstrategie
24.11.2020
Austrian study provides deep insights into transmission and mutation properties of SARS-CoV-2
23.11.2020
Marinomed Biotech plans clinical trial with Carragelose nasal spray to investigate prevention of COVID-19 infection in frontline healthcare staff
20.11.2020
APEPTICO and the Solnatide H2020 team participated in the ePitching to procurers on COVID-19 initiated by the European Innovation Council
20.11.2020
COVID-19: Treatment for the most severely affected patients - after promising results in “named patient use” - clinical trial with FX06 starts in France.
19.11.2020
Stammzelltransplantation: Mechanismus für unerwünschte Abstoßungsreaktion identifiziert
19.11.2020
COVID-19: Treatment for the Most Severely Affected Patients - After Promising Results in Named Patient Use - Clinical Trial with FX06 Starts in France
19.11.2020
Eveliqure announces the publication of key preclinical data for its clinical stage vaccine candidate against Shigellosis and ETEC
18.11.2020
Drug discovery: First highly scalable method developed to monitor protein levels and localizations in cells
18.11.2020
Technology transfer fund KHAN-I and w4i conclude framework agreement with 19 Austrian research institutes
17.11.2020
Technologietransfer-Fonds KHAN-I und w4i schließen Rahmenvereinbarung mit 19 österreichischen Forschungseinrichtungen